"10.1371_journal.pone.0107934","plos one","2014-09-25T00:00:00Z","Norikazu Hinamoto; Yohei Maeshima; Hiroko Yamasaki; Tatsuyo Nasu; Daisuke Saito; Hiroyuki Watatani; Haruyo Ujike; Katsuyuki Tanabe; Kana Masuda; Yuka Arata; Hitoshi Sugiyama; Yasufumi Sato; Hirofumi Makino","Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; Department of Chronic Kidney Disease and Cardiovascular Disease, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; Department of Chronic Kidney Disease and Peritoneal Dialysis, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan; Department of Vascular Biology, Institute of Development, Aging, and Cancer, Tohoku University, Sendai, Japan","Conceived and designed the experiments: NH YM. Performed the experiments: NH HY TN DS HW HU KT KM YA. Analyzed the data: NH YM. Contributed reagents/materials/analysis tools: NH DS YM. Contributed to the writing of the manuscript: NH YM HM HS YS.","The authors have read the journals policy and the authors of this manuscript have the following competing interests: Prof. Yohei Maeshima belongs to endowed department by Chugai pharmaceutical, MSD, Boehringer ingelheim and Kawanishi Holdings. Prof. Hitoshi Sugiyama belongs to endowed department by Baxter. Prof. Hirofumi Makino is a consultant for AbbVie, Astellas and Teijin, receives speaker honoraria from Astellas, Boehringer-ingelheim, Chugai, Daiichi Sankyo, Dainippon Sumitomo, Kyowa Hakko Kirin, MSD, Novartis, Pfizer, Takeda and Tanabe Mitsubishi, and receives grant support from Astellas, Boehringer-ingelheim, Daiichi Sankyo, Dainippon Sumitomo, Kyowa Hakko Kirin, Mochida, MSD, Novartis, Novo Nordisk, Pfizer, Takeda and Tanabe Mitsubishi. Any other authors dont have competing interests. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2014","09","Norikazu Hinamoto","NH",13,TRUE,2,9,2,NA,TRUE,TRUE,FALSE,0,NA,FALSE
